Currently polymerase chain-reaction (PCR) testing of eye-swabs and clinical examination for inflammation are the most established diagnostic tools for monitoring trachoma surveillance within the key indicator group of 1-9 year olds [5], although the vast majority of programmatic decisions are currently made based only on TF prevalence. The gene discussed is TF; the disease is inclusion conjunctivitis.